$GDLG
Glidelogic Corp.

2023 Q2 Form 10-K Financial Statement

#000184867223000007 Filed on April 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2023
Revenue $0.00 $100.7K $243.1K
YoY Change 892.08%
Cost Of Revenue $80.20K $210.3K
YoY Change
Gross Profit $20.53K $32.73K
YoY Change 33.58%
Gross Profit Margin 20.38% 13.46%
Selling, General & Admin $24.06K $47.33K
YoY Change 87.52%
% of Gross Profit 117.19% 144.63%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $105.00 $110.00 $2.300K
YoY Change -91.46% -20.96%
% of Gross Profit 0.54% 7.03%
Operating Expenses $8.750K $24.06K $47.33K
YoY Change 141.05% 87.52%
Operating Profit -$8.750K -$3.530K $14.61K
YoY Change 141.05% 1868.73%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$3.530K
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$8.750K -$3.530K -$14.61K
YoY Change 141.05% 1868.73%
Net Earnings / Revenue -3.5% -6.01%
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00 -$0.01
COMMON SHARES
Basic Shares Outstanding 2.664M shares 2.664M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2 2023 Q1 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.900K $14.55K $14.55K
YoY Change -58.08%
Cash & Equivalents $5.902K $14.55K $14.55K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $5.902K $14.55K $14.55K
YoY Change -58.09% -58.08%
LONG-TERM ASSETS
Property, Plant & Equipment $3.648K $3.753K $3.750K
YoY Change 1.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $3.648K $3.753K $3.750K
YoY Change 1.57% 1.35%
TOTAL ASSETS
Total Short-Term Assets $5.902K $14.55K $14.55K
Total Long-Term Assets $3.648K $3.753K $3.750K
Total Assets $9.550K $18.30K $18.30K
YoY Change -52.35% -52.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00
YoY Change -100.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $6.010K $6.010K $6.010K
YoY Change 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.010K $6.010K $6.010K
YoY Change -47.78% -47.78%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.010K $6.010K $6.010K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $6.010K $6.010K $6.010K
YoY Change -47.78% -47.78%
SHAREHOLDERS EQUITY
Retained Earnings -$25.01K $16.26K
YoY Change -1084.26%
Common Stock $2.664K $2.664K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.540K $12.29K $12.29K
YoY Change
Total Liabilities & Shareholders Equity $9.550K $18.30K $18.30K
YoY Change -52.35% -52.36%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2023
OPERATING ACTIVITIES
Net Income -$8.750K -$3.530K -$14.61K
YoY Change 141.05% 1868.73%
Depreciation, Depletion And Amortization $105.00 $110.00 $2.300K
YoY Change -91.46% -20.96%
Cash From Operating Activities -$8.645K -$3.420K $17.81K
YoY Change 9.43% -305.86%
INVESTING ACTIVITIES
Capital Expenditures $2.350K $2.350K
YoY Change -64.39%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$2.350K $2.353K
YoY Change -64.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $0.00 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -$8.645K -3.420K $17.81K
Cash From Investing Activities $0.00 -2.350K $2.353K
Cash From Financing Activities $0.00 0.000
Net Change In Cash -$8.645K -5.770K $20.17K
YoY Change -33.9%
FREE CASH FLOW
Cash From Operating Activities -$8.645K -$3.420K $17.81K
Capital Expenditures $2.350K $2.350K
Free Cash Flow -$5.770K $15.46K
YoY Change -201.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei City Area Code
CityAreaCode
786
CY2023 dei Local Phone Number
LocalPhoneNumber
708-6089
CY2023 dei Contact Personnel Email Address
ContactPersonnelEmailAddress
[email protected]
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001848672
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2023 us-gaap Loans And Leases Receivable Related Parties Period Increase Decrease
LoansAndLeasesReceivableRelatedPartiesPeriodIncreaseDecrease
usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
CY2023 us-gaap Interest Paid
InterestPaid
usd
CY2022 us-gaap Interest Paid
InterestPaid
usd
CY2023 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-01-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
333-254750
CY2023 dei Entity Registrant Name
EntityRegistrantName
GLIDELOGIC CORP.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1575837
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
21/1 Erkindik Ave, ste. 187
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Bishkek
CY2023 dei Entity Address Country
EntityAddressCountry
KG
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
720000
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Public Float
EntityPublicFloat
0 usd
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2663750 shares
CY2023 dei Auditor Name
AuditorName
Fruci & Associates
CY2023 dei Auditor Firm
AuditorFirmId
5525
CY2023 dei Auditor Location
AuditorLocation
Spokane, Washington
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14547 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34713 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
14547 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
34713 usd
CY2023Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
3753 usd
CY2022Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
3695 usd
CY2023Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
3753 usd
CY2022Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
3695 usd
CY2023Q1 us-gaap Assets
Assets
18300 usd
CY2022Q1 us-gaap Assets
Assets
38408 usd
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
5500 usd
CY2023Q1 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
6010 usd
CY2022Q1 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
6010 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6010 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
11510 usd
CY2023Q1 us-gaap Liabilities
Liabilities
6010 usd
CY2022Q1 us-gaap Liabilities
Liabilities
11510 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2663750 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2663750 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2663750 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2663750 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
2664 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
2664 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25886 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25886 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
16260 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1652 usd
CY2023Q1 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
12290 usd
CY2022Q1 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
26898 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18300 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38408 usd
CY2023 us-gaap Revenues
Revenues
243060 usd
CY2022 us-gaap Revenues
Revenues
24500 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
210334 usd
CY2023 us-gaap Gross Profit
GrossProfit
32726 usd
CY2022 us-gaap Gross Profit
GrossProfit
24500 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47334 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25242 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
47334 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
25242 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
14608 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
742 usd
CY2023 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
14608 usd
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
742 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2663750 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2132020 shares
CY2021Q1 us-gaap Shares Outstanding
SharesOutstanding
2000000 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1090 usd
CY2022 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
663750 shares
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
26550 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-742 usd
CY2022Q1 us-gaap Shares Outstanding
SharesOutstanding
2663750 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
26898 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-14608 usd
CY2023Q1 us-gaap Shares Outstanding
SharesOutstanding
2663750 shares
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
12290 usd
CY2023 us-gaap Profit Loss
ProfitLoss
14608 usd
CY2022 us-gaap Profit Loss
ProfitLoss
742 usd
CY2023 us-gaap Depreciation Expense On Reclassified Assets
DepreciationExpenseOnReclassifiedAssets
2295 usd
CY2022 us-gaap Depreciation Expense On Reclassified Assets
DepreciationExpenseOnReclassifiedAssets
2905 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
990 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5500 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5500 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17813 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8653 usd
CY2023 gdlg Equipment
Equipment
2353 usd
CY2022 gdlg Equipment
Equipment
6600 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
2353 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6600 usd
CY2022 us-gaap Loans And Leases Receivable Related Parties Period Increase Decrease
LoansAndLeasesReceivableRelatedPartiesPeriodIncreaseDecrease
6010 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
26550 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32560 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
20165 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-34613 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34713 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
100 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14547 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
34713 usd
CY2023 us-gaap Revenues
Revenues
243060 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_842_eus-gaap--UseOfEstimates_zP21DNV6aVR6" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span id="xdx_86C_zYQ1lJVPJqei">Use of Estimates</span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"> </p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"> </p>
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3259 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-156 usd
CY2023 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
3259 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
156 usd
CY2023Q1 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
6010 usd
CY2023Q1 us-gaap Shares Issued
SharesIssued
2663750 shares
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16260 usd
CY2022Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1652 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3415 usd
CY2022Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
347 usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3415 usd
CY2022Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
347 usd

Files In Submission

Name View Source Status
0001848672-23-000007-index-headers.html Edgar Link pending
0001848672-23-000007-index.html Edgar Link pending
0001848672-23-000007.txt Edgar Link pending
0001848672-23-000007-xbrl.zip Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gdlg-20230131.xsd Edgar Link pending
gdlg10k2023.htm Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gdlg-20230131_cal.xml Edgar Link unprocessable
gdlg-20230131_def.xml Edgar Link unprocessable
gdlg-20230131_pre.xml Edgar Link unprocessable
gdlg-20230131_lab.xml Edgar Link unprocessable
gdlg10k2023_htm.xml Edgar Link completed